Alex Callo

Alex Callo represents clients in civil litigation matters, particularly related to high-stakes intellectual property disputes (including pharmaceutical patent litigation under the Hatch-Waxman Act). Alex’s intellectual property practice touches on a range of technologies, with a focus on small molecule drugs, biologics and medical devices. As a member on the firm’s Pro Bono Committee, Alex has represented individuals pro bono in both state and federal court (e.g., related to litigation under 42 U.S.C. § 1983). His experience includes drafting motions and pleadings, oral advocacy, research, and analyzing discovery.

Alex has an educational background in both intellectual property law and the life sciences. As an undergraduate student, he completed an externship at the U.S. Patent and Trademark Office, during which he assessed patent applications and drafted Office Actions on semiconductor patent applications. Alex also performed undergraduate research in the field of targeted nano-drug delivery while at Virginia Tech. He was also an assistant life sciences technology transfer associate, which involved identifying, researching and communicating with prospective companies willing to license biotechnological devices and methods developed at Virginia Tech, as well as conducting prior art searches in the biomedical field.